Quest for new mental illness treatments continues with MDMA and psilocybin trial
Examiner, January 18, 2022
New research looking into the effects of MDMA and psilocybin on the brain is set to take place as part of a continuing push to make psychedelic medicines a mainstream treatment for depression and other mental health disorders
The Power of Psychedelic Assisted Therapies
Crappy to Happy Podcast, January 14, 2022
In this episode of the Crappy to Happy podcast, host Cass Dunn chats with Tania de Jong AM, who is a social entrepreneur, incredibly talented soprano and co-founder of the not-for-profit, Mind Medicine Australia.
Mind Medicine Australia joins global coalition launched to secure a rescheduling of psilocybin under the 1971 UN Convention on Psychotropic Substances
Mind Medicine Australia, January 13, 2022
Today Mind Medicine Australia joins in the launch of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI), a global coalition working to promote and secure a rescheduling of psilocybin under the 1971 Convention on Psychotropic Substances
Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines
Mind Medicine Australia, January 10, 2022
Mind Medicine Australia (MMA) is delighted to announce that it is part-funding a clinical trial which has just received Human Research Ethics approval and is designed to study the brain activity of participants after taking psychedelic medicines.
Find Your Voice: How This Acclaimed Australian Soprano Believes That Together We Can Change The World One Voice At A Time
Finding Genius Podcast, December 24, 2021
Our Executive Director Tania de Jong AM was interviewed in this podcast about her work with mental health charities Creativity Australia and Mind Medicine Australia.
From Investment Banking To Psychedelics: Changing The Treatment Paradigm For Mental Illness With Peter Hunt
Wake the f*** up podcast, December 21, 2021
This podcast is an exploration into Peter Hunt’s journey into spirituality and finding greater connection, meaning and peace which led to the establishment of Mind Medicine Australia with his wife Tania de Jong. It also explains why it is so urgent for psychedelic-assisted therapies to become part of our mental health system and the importance of Governments becoming proactive in this field, rather than reactive. There is so much suffering which could be alleviated through these transformational therapies.
Emyria to expand Real World Data assets for MDMA-assisted therapy trials by incorporating wearables monitoring
Emyria (ASX: EMD ) Press Release, December 20, 2021
Emyria’s phase 2b MDMA-assisted therapy trial for severe Post Traumatic Stress Disorder (PTSD), EMDMA-001, developed with registered charity Mind Medicine Australia (MMA), will be the first program to incorporate Cydelic technology and is expected to be one of the first programs in the world to incorporate remote patient monitoring within MDMA-assisted therapy.
TGA blocks use of MDMA, magic mushrooms trials for mental health
AFR, December 17, 2021
Australia’s medicines regulator has rejected a call to legalise psychedelic drugs for use in mental health settings.
TGA blocks bid to have MDMA, magic mushrooms used to treat mental health conditions
ABC News, December 16, 2021
Australia’s medicines regulator has rejected a call to legalise psychedelic drugs for use in mental health settings.
The Wellness Couch Podcast, Episode #92 with Tania de Jong AM
The Wellness Couch Podcast, December 16, 2021
In this podcast, Mind Medicine Australia Executive Director, Tania de Jong AM, shares more about psychedelic-assisted psychotherapies and their potential for healing mental illness.
TGA says NO again to psychedelic-assisted therapies
Mind Medicine Australia, December 15, 2021
Mind Medicine Australia’s Response to the Announcement of the TGA NOT to Reschedule the Medical Use of MDMA for Treatment Resistant PTSD and the Medical Use of Psilocybin for Treatment Resistant Depression as Part of Therapy.
MDMA and psilocybin could be removed from the TGA’s list of prohibited medicines
ABC RN Breakfast, December 3, 2021
In this interview MMA Ambassador, Prof David Nutt (UK), speaks about Australia’s drug regulator, the Therapeutic Goods Administration, who is soon set to announce if psilocybin and MDMA should be removed from the prohibited medicines list: “I have to say, one of the things I have been doing a lot here is teaching on Mind Medicine Australia training course which I think is the best course in the world on educating people about how to use psychedelics and how to develop.” (6:19 onwards)
Return trip: Psychedelics have made a comeback in the treatment of mental illness
Wellspring Mag, December 1, 2021
In this interview, Tania de Jong AM, Executive Director at Mind Medicine Australia, discusses the re-emergence of psychedelic-assisted therapies.
A former defence force chief has joined a push to treat post traumatic stress disorder with MDMA
9 News, November 18, 2021
Admiral Chris Barrie AC, a former Defence Force Chief from our board and Veteran Michael Raymond were recently interviewed on 9News. We are advocating for psychedelic medicines which can offer hope to those suffering from severe PTSD and depression.
TGA considering change to classification of psychedelics
ABC News, November 17, 2021
Psychiatrist Dr Stuart Saker says there’s compelling evidence that some psychedelic drugs make effective treatments for people with post-traumatic stress disorder or depression.
Momentum for psychedelic-assisted therapies building in New Zealand
News Hub, October 30, 2021
“Sometimes the government has a chance to do something fantastic. And something revolutionary, and this would be one of those times.”
Clinical use of psilocybin
9News Gold Coast, October 22, 2021
The clinical use of magic mushrooms and ecstasy to treat mental illness could soon be available to every Australian. A former Rugby player and Gold Cost local now throwing his support behind the unorthodox approach.
TGA review psychedelics for mental health treatment
ABC, RN Breakfast, October 7, 2021
A review by an independent expert panel has found MDMA and psilocybin or ‘magic mushrooms’ may show promise for therapeutic use.
They could be used in clinical therapies to treat depression, post traumatic stress disorder (PTSD) and other complex mental illnesses, in a controlled environment.
‘Psychedelics renaissance’: new wave of research puts hallucinogenics forward to treat mental health
The Guardian, September 26, 2021
In what’s been described as a ‘paradigm shifter’ for psychiatry, Australian clinical trials are exploring the therapeutic benefits of illegal substances.
How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with Psychedelics
Psychedelic Spotlight, September 16, 2021
Charity co-founder Tania de Jong says Covid-19 pandemic has led to “a huge spike in mental health issues including, very sadly, suicides,” and she believes psychedelics are a solution.